AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2008
Nov 20, 2008
32254_dirs_2008-11-20_700fd545-6c92-4f52-97a0-1b58f5ca3837.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2008-11-18
Reporting Person: ROGERS MICHAEL W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-11-18 | Employee Stock Option (right to buy) | $1.13 | A | 100000 | Acquired | 2018-11-18 | Common Stock (100000) | Direct |
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7